TrueShares Structured Outcome (February) ETF (BATS:FEBZ) Shares Up 0.1%
TrueShares Structured Outcome (February) ETF (BATS:FEBZ) Shares Up 0.1%
Shares of TrueShares Structured Outcome (February) ETF (BATS:FEBZ – Get Rating) shot up 0.1% during mid-day trading on Monday . The company traded as high as $27.64 and last traded at $27.64. 500 shares traded hands during mid-day trading, The stock had previously closed at $27.62.
TrueShares結構化結果(2月)ETF(BATS:FEBZ-GET Rating)的股價在週一午盤交易中飆升0.1%。該公司股價一度高達27.64美元,最新報27.64美元。午盤交易中有500股易手,該股此前收盤報27.62美元。
TrueShares Structured Outcome (February) ETF Stock Down 0.1 %
TrueShares結構性結果(2月)ETF股價下跌0.1%
The company has a fifty day moving average of $26.29 and a 200 day moving average of $26.57.
該公司的50日移動均線切入位在26.29美元,200日移動均線切入位在26.57美元。
Hedge Funds Weigh In On TrueShares Structured Outcome (February) ETF
對衝基金參與TrueShares結構化結果(2月)ETF
Large investors have recently bought and sold shares of the business. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of TrueShares Structured Outcome (February) ETF in the first quarter valued at approximately $722,000. OLD Mission Capital LLC grew its stake in TrueShares Structured Outcome (February) ETF by 246.0% in the 2nd quarter. OLD Mission Capital LLC now owns 28,286 shares of the company's stock valued at $728,000 after acquiring an additional 20,110 shares during the period. Finally, Castleview Partners LLC increased its holdings in TrueShares Structured Outcome (February) ETF by 10.6% in the 2nd quarter. Castleview Partners LLC now owns 13,101 shares of the company's stock worth $327,000 after acquiring an additional 1,259 shares in the last quarter.
大型投資者最近買賣了該公司的股票。劍橋投資研究顧問公司在第一季度購買了TrueShares結構化結果(2月)ETF的新股,價值約722,000美元。舊使命資本有限責任公司在第二季度增持了TrueShares結構性結果(2月)ETF的股份246.0%。在此期間增持了20,110股後,Old May Capital LLC現在擁有28,286股該公司的股票,價值728,000美元。最後,Castleview Partners LLC在第二季度增持了TrueShares結構化結果(2月)ETF 10.6%。Castleview Partners LLC在上個季度增持了1,259股後,現在擁有13,101股該公司股票,價值327,000美元。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on TrueShares Structured Outcome (February) ETF (FEBZ)
- Hormel: Is This The Time To Buy?
- Struggling Axsome Stock Could Bounce Back on Drug Trial Success
- Which Stocks Are Black Friday, Cyber Monday Winners & Losers?
- Three Reasons It's Time To Get Bullish On Organigram
- Opportunity Strikes! Hibbett, Inc Falls Flat On Strong Results
- 免費獲取StockNews.com關於TrueShares結構化結果(2月)ETF(FEBZ)的研究報告
- 霍梅爾:現在是買進的時候嗎?
- 苦苦掙扎的Axome股票可能因藥物試驗成功而反彈
- 哪些股票是黑色星期五,網絡星期一的贏家和輸家?
- 看好Organigram的三個原因
- 機遇來了!Hibbett,Inc.業績強勁,股價持平
Receive News & Ratings for TrueShares Structured Outcome (February) ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueShares Structured Outcome (February) ETF and related companies with MarketBeat.com's FREE daily email newsletter.
獲得TrueShares結構化結果的新聞和評級(2月)ETF Daily-在下面輸入您的電子郵件地址,以通過MarketBeat.com的免費每日電子郵件時事通訊接收對TrueShares結構化結果(2月)ETF和相關公司的最新新聞和分析師評級的每日摘要。
譯文內容由第三人軟體翻譯。